Please login to the form below

Not currently logged in
Email:
Password:

Brineura

This page shows the latest Brineura news and features for those working in and with pharma, biotech and healthcare.

BioMarin ticks over in Q2 ahead of gene therapy filing

BioMarin ticks over in Q2 ahead of gene therapy filing

our late stage clinical programmes, and higher marketing and sales expenses in support of the commercial launches of Palynziq and Brineura”. ... BioMarin will also hope to extend the commercial success of Brineura, its Batten disease therapy.

Latest news

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Nektar Therapeutics appoints Jeff Ajer Nektar Therapeutics appoints Jeff Ajer

    officer. There he worked on establishing BioMarin’s global footprint and commercial infrastructure and has played a leadership role in the launches and growth strategies for brands including Brineura, Vimizim, Kuvan

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics